首页> 外国专利> INDUCTION OF REV AND TAT SPECIFIC CYTOTOXIC T-CELLS FOR PREVENTION AND TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION

INDUCTION OF REV AND TAT SPECIFIC CYTOTOXIC T-CELLS FOR PREVENTION AND TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION

机译:诱导REV和TAT特异性细胞毒性T细胞预防和治疗人类免疫缺陷病毒(HIV)感染

摘要

PPROBLEM TO BE SOLVED: To provide a method and composition (including immunologic composition such as vaccine) targeting prevention and treatment of AIDS. PSOLUTION: The presence of cytotoxic T-cells to the Rev and/or Tat protein in samples from a subject infected with immunodeficiency virus, particularly HIV in humans, is an indication of a stable disease condition and a favorable prognosis of lack of progression of disease. Immunogenic compositions containing at least one cytotoxic T-cell epitope of the Rev and/or Tat protein of an immunodeficiency virus, particularly HIV, or a vector encoding the T-cell epitope, may be used to prevent infection by disease caused by the immunodeficiency virus, by inducing, in the host, a specific cytotoxic T-cell response specific for the respective Rev and/or Tat proteins. PCOPYRIGHT: (C)2007,JPO&INPIT
机译:

要解决的问题:提供一种针对艾滋病的预防和治疗的方法和组合物(包括疫苗等免疫学组合物)。

解决方案:在感染了免疫缺陷病毒特别是人类HIV的受试者的样品中,存在针对Rev和/或Tat蛋白的细胞毒性T细胞,这表明疾病状况稳定,且预后良好疾病进展。包含免疫缺陷病毒,特别是HIV的Rev和/或Tat蛋白的至少一种细胞毒性T细胞表位的免疫原性组合物,或编码该T细胞表位的载体,可用于预防由免疫缺陷病毒引起的疾病的感染。通过在宿主中诱导对各自的Rev和/或Tat蛋白具有特异性的特异性细胞毒性T细胞应答。

版权:(C)2007,日本特许厅&INPIT

著录项

  • 公开/公告号JP2006265255A

    专利类型

  • 公开/公告日2006-10-05

    原文格式PDF

  • 申请/专利权人 ERASMUS UNIV ROTTERDAM;

    申请/专利号JP20060093367

  • 申请日2006-03-30

  • 分类号A61K39/21;A61P31/18;C12Q1/02;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 21:54:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号